Dr Rachel Burke Glass, DO in Alma, GA - Pediatrics

Dr Rachel Burke Glass, DO is a Pediatrics physician based in Alma, Georgia. Dr Rachel Burke Glass is licensed to practice in Georgia (license number 066997) and her current practice location is 1112 W 12th St, Alma, Georgia. She can be reached at her office (for appointments etc.) via phone at (912) 632-8244.

NPI number for Dr Rachel Burke Glass is 1275777971 and her current mailing address is 1112 W 12th St, Alma, Georgia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1275777971.

Contact Information

	Dr Rachel Burke Glass, DO
	1112 W 12th St, Alma, GA 31510-1814
	(912) 632-8244
	(912) 632-7041

Physician's Profile

Full Name	Dr Rachel Burke Glass
Gender	Female
Speciality	Pediatrics
Location	1112 W 12th St, Alma, Georgia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1275777971
Provider Enumeration Date: 04/24/2009
Last Update Date: 01/14/2022

Medical Identifiers

Medical identifiers for Dr Rachel Burke Glass such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275777971	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	066997 (Georgia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rachel Burke Glass is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Rachel Burke Glass, DO 1112 W 12th St, Alma, GA 31510-1814 Ph: (912) 632-8244	Dr Rachel Burke Glass, DO 1112 W 12th St, Alma, GA 31510-1814 Ph: (912) 632-8244

News Archive

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

Interventional Spine, Inc., a privately held medical device manufacturer focusing on diseases of the spine, will present at the Spine Technology Summit at the Roosevelt Hotel in New Orleans on Monday April 26th. This annual event is a showcase for 40 new technology companies and attracts investors, industry, practitioners and analysts.

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis.

PureSafety launches industry's first Learning and Safety Management System

PureSafety, a leading provider of training, safety, occupational health and medical management software and information solutions, today announced the release of the industry's first Learning and Safety Management System (LSMS).

New tobacco regulations and FDA rules authorized by Family Smoking and Prevention Act to be released

Starting tomorrow (June 22), new regulations and FDA rules authorized by the Family Smoking and Prevention Act will further limit the tobacco industry's ability to deceive consumers with misleading marketing and labeling that imply "light," "mild" or "low-tar" cigarettes are safer, as well as other practices that make products more appealing to youth.

Bedfont needs public support to represent the UK in European Business Awards

Bedfont has submitted a video entry to represent the UK and now needs the help of the public to be voted the European Public Winner.

Dr Rachel Burke Glass, DO - Pediatrics in Alma, GA